Valuation Sanofi

Stocks

Market Closed - Euronext Paris Other stock markets 11:55:00 2026-06-12 EDT			5-day change	1st Jan Change
76.59 ^EUR	+0.38%		-1.74%	-7.41%

06-13	Sanofi - Shareholder/Analyst Call
06-12	FDA approves expanded use of Sanofi's type 1 diabetes drug	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	111,194	112,665	112,549	116,968	100,655	91,925	-	-
Change	-	1.32%	-0.1%	3.93%	-13.95%	-8.67%	-	-
Enterprise Value (EV) ¹	121,177	119,102	120,342	125,740	111,663	102,728	100,008	98,928
Change	-	-1.71%	1.04%	4.49%	-11.2%	-8%	-2.65%	-1.08%
P/E Ratio	17.8x	16.7x	20.8x	20.4x	12.9x	11.4x	10.6x	9.17x
PBR	1.62x	1.5x	1.52x	1.51x	1.41x	1.23x	1.17x	1.1x
PEG	-	2.07x	-1.1x	3.14x	0.3x	2.26x	1.46x	0.6x
Capitalization / Revenue	2.94x	2.62x	2.61x	2.85x	2.31x	1.95x	1.84x	1.75x
EV / Revenue	3.21x	2.77x	2.79x	3.06x	2.56x	2.18x	2x	1.89x
EV / EBITDA	9.95x	8.14x	8.44x	9.76x	8.22x	7.05x	6.48x	5.85x
EV / EBIT	11.3x	9.13x	9.5x	11.1x	9.19x	8.01x	7.31x	6.59x
EV / FCF	15x	14x	14.2x	21.1x	13.8x	12x	11x	9.65x
FCF Yield	6.68%	7.12%	7.04%	4.74%	7.24%	8.36%	9.13%	10.4%
Dividend per Share ²	3.33	3.56	3.76	3.92	4.12	4.256	4.508	4.833
Rate of return	3.76%	3.96%	4.19%	4.18%	4.98%	5.56%	5.89%	6.31%
EPS ²	4.97	5.37	4.31	4.59	6.4	6.723	7.211	8.354
Distribution rate	67%	66.3%	87.2%	85.4%	64.4%	63.3%	62.5%	57.9%
Net sales ¹	37,761	42,997	43,070	41,081	43,626	47,068	49,980	52,476
EBITDA ¹	12,183	14,627	14,259	12,889	13,583	14,567	15,445	16,899
EBIT ¹	10,714	13,040	12,670	11,343	12,149	12,826	13,680	15,023
Net income ¹	6,223	6,720	5,400	5,744	7,813	8,145	8,955	10,358
Net Debt ¹	9,983	6,437	7,793	8,772	11,008	10,803	8,083	7,003
Reference price ²	88.58	89.84	89.76	93.74	82.72	76.59	76.59	76.59
Nbr of stocks (in thousands)	1,255,293	1,254,060	1,253,891	1,247,793	1,216,810	1,200,220	-	-
Announcement Date	2/4/22	2/3/23	2/1/24	1/30/25	1/29/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SANOFI	11.39x	2.18x	7.05x	5.56%	106B
ELI LILLY AND COMPANY	33.15x	12.05x	24.81x	0.6%	1,010B
JOHNSON & JOHNSON	25.74x	5.93x	16.13x	2.22%	580B
ABBVIE INC.	27.88x	6.79x	13.86x	3.01%	402B
ROCHE HOLDING AG	17.71x	4.37x	10.73x	3.04%	330B
NOVARTIS AG	21.24x	5.49x	13.32x	2.92%	281B
ASTRAZENECA PLC	22.78x	4.74x	13.47x	1.85%	280B
NOVO NORDISK A/S	12.7x	4.76x	9.73x	3.95%	197B
AMGEN INC.	23.09x	6.16x	10.76x	2.84%	192B
GILEAD SCIENCES, INC.	-45x	5.43x	29.95x	2.58%	156B
Average	15.07x	5.79x	14.98x	2.86%	353.54B
Weighted average by Cap.	22.34x	7.31x	17.10x	2.2%